. 2011 Apr;92(2):97–105. doi: 10.1111/j.1365-2613.2010.00747.x

Table 3.

Immunofluorescence analysis of CD44, CD133 and CD176 expression in lung, breast and liver cancer tissues (per cent of carcinoma cells belonging to the respective group)

Cancer type	CD44⁻/CD176⁻ (%)	CD44⁻/CD176⁺ (%)	CD44⁺/CD176⁻ (%)	CD44⁺/CD176⁺ (%)	CD133⁻/CD176⁻ (%)	CD133⁻/CD176⁺ (%)	CD133⁺/CD176⁻ (%)	CD133⁺/CD176⁺ (%)
Lung carcinoma (NSCLC)	1–5	<1	30–60	5–30	>60	5–30	1–5	1–5
Breast carcinoma	5–30	1–5	5–30	5–30	>60	5–30	1–5	1–5
Liver carcinoma (HCC)	1–5	1–5	30–60	5–30	>60	1–5	1–5	5–30

NSCLC, non-small cell lung carcinoma; HCC, hepatocellular carcinoma.